Emerald Mutual Fund Advisers Trust Oric Pharmaceuticals, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$12.01 - $20.3 $8.92 Million - $15.1 Million	-742,666 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$15.9 - $25.22 $2.95 Million - $4.68 Million	185,456 Added 33.28%	742,666 $15.5 Million
Q2 2021 Jul 29, 2021	SELL	$17.37 - $25.34 $1.16 Million - $1.7 Million	-67,000 Reduced 10.73%	557,210 $9.86 Million
Q1 2021 Apr 29, 2021	BUY	$23.67 - $36.85 $3.22 Million - $5.01 Million	135,976 Added 27.85%	624,210 $15.3 Million
Q4 2020 Jan 29, 2021	BUY	$20.32 - $39.8 $3.57 Million - $6.99 Million	175,751 Added 56.24%	488,234 $16.5 Million
Q3 2020 Oct 28, 2020	BUY	$19.5 - $31.26 $2.79 Million - $4.48 Million	143,315 Added 84.72%	312,483 $7.82 Million
Q2 2020 Jul 28, 2020	BUY	$25.68 - $38.12 $4.34 Million - $6.45 Million	169,168 New	169,168 $5.71 Million

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.